Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Friedreich Ataxia Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Friedreich Ataxia Drugmarket, defines the market attractiveness level of Friedreich Ataxia Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Friedreich Ataxia Drug industry, describes the types of Friedreich Ataxia Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Friedreich Ataxia Drug market and the development prospects and opportunities of Friedreich Ataxia Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Friedreich Ataxia Drug market in Chapter 13.
By Player:
Adverum Biotechnologies Inc
RaNA Therapeutics Inc
ProQR Therapeutics NV
Forward Pharma A/S
Shire Plc
Reata Pharmaceuticals Inc
Voyager Therapeutics Inc
Ixchel Pharma LLC
STATegics Inc
Pfizer Inc
Cardero Therapeutics Inc
Retrotope Inc
By Type:
ADVM-063
AGIL-FA
BHV-4157
BVA-202
Others
By End-User:
Clinic
Hospital
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Friedreich Ataxia Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Friedreich Ataxia Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Friedreich Ataxia Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Friedreich Ataxia Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Friedreich Ataxia Drug Market Analysis and Outlook to 2022
-
7.1 Global Friedreich Ataxia Drug Consumption (2017-2022)
-
7.2 United States Friedreich Ataxia Drug Consumption (2017-2022)
-
7.3 Europe Friedreich Ataxia Drug Consumption (2017-2022)
-
7.4 China Friedreich Ataxia Drug Consumption (2017-2022)
-
7.5 Japan Friedreich Ataxia Drug Consumption (2017-2022)
-
7.6 India Friedreich Ataxia Drug Consumption (2017-2022)
-
7.7 South Korea Friedreich Ataxia Drug Consumption (2017-2022)
8 Region and Country-wise Friedreich Ataxia Drug Market Analysis and Outlook to 2028
-
8.1 Global Friedreich Ataxia Drug Consumption Forecast (2022-2028)
-
8.2 United States Friedreich Ataxia Drug Consumption Forecast (2022-2028)
-
8.3 Europe Friedreich Ataxia Drug Consumption Forecast (2022-2028)
-
8.4 China Friedreich Ataxia Drug Consumption Forecast (2022-2028)
-
8.5 Japan Friedreich Ataxia Drug Consumption Forecast (2022-2028)
-
8.6 India Friedreich Ataxia Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Friedreich Ataxia Drug Consumption Forecast (2022-2028)
9 Global Friedreich Ataxia Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Friedreich Ataxia Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global ADVM-063 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global AGIL-FA Consumption and Growth Rate (2017-2022)
-
9.1.3 Global BHV-4157 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global BVA-202 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Friedreich Ataxia Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Friedreich Ataxia Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Friedreich Ataxia Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global ADVM-063 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global AGIL-FA Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global BHV-4157 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global BVA-202 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Friedreich Ataxia Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Friedreich Ataxia Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Friedreich Ataxia Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Friedreich Ataxia Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Friedreich Ataxia Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Friedreich Ataxia Drug Market Competitive Analysis
-
14.1 Adverum Biotechnologies Inc
-
14.1.1 Adverum Biotechnologies Inc Company Details
-
14.1.2 Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Adverum Biotechnologies Inc Friedreich Ataxia Drug Product and Service
-
14.2 RaNA Therapeutics Inc
-
14.2.1 RaNA Therapeutics Inc Company Details
-
14.2.2 RaNA Therapeutics Inc Friedreich Ataxia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 RaNA Therapeutics Inc Friedreich Ataxia Drug Product and Service
-
14.3 ProQR Therapeutics NV
-
14.3.1 ProQR Therapeutics NV Company Details
-
14.3.2 ProQR Therapeutics NV Friedreich Ataxia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 ProQR Therapeutics NV Friedreich Ataxia Drug Product and Service
-
14.4 Forward Pharma A/S
-
14.4.1 Forward Pharma A/S Company Details
-
14.4.2 Forward Pharma A/S Friedreich Ataxia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Forward Pharma A/S Friedreich Ataxia Drug Product and Service
-
14.5 Shire Plc
-
14.5.1 Shire Plc Company Details
-
14.5.2 Shire Plc Friedreich Ataxia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Shire Plc Friedreich Ataxia Drug Product and Service
-
14.6 Reata Pharmaceuticals Inc
-
14.6.1 Reata Pharmaceuticals Inc Company Details
-
14.6.2 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Product and Service
-
14.7 Voyager Therapeutics Inc
-
14.7.1 Voyager Therapeutics Inc Company Details
-
14.7.2 Voyager Therapeutics Inc Friedreich Ataxia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Voyager Therapeutics Inc Friedreich Ataxia Drug Product and Service
-
14.8 Ixchel Pharma LLC
-
14.8.1 Ixchel Pharma LLC Company Details
-
14.8.2 Ixchel Pharma LLC Friedreich Ataxia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Ixchel Pharma LLC Friedreich Ataxia Drug Product and Service
-
14.9 STATegics Inc
-
14.9.1 STATegics Inc Company Details
-
14.9.2 STATegics Inc Friedreich Ataxia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 STATegics Inc Friedreich Ataxia Drug Product and Service
-
14.10 Pfizer Inc
-
14.10.1 Pfizer Inc Company Details
-
14.10.2 Pfizer Inc Friedreich Ataxia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Pfizer Inc Friedreich Ataxia Drug Product and Service
-
14.11 Cardero Therapeutics Inc
-
14.11.1 Cardero Therapeutics Inc Company Details
-
14.11.2 Cardero Therapeutics Inc Friedreich Ataxia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Cardero Therapeutics Inc Friedreich Ataxia Drug Product and Service
-
14.12 Retrotope Inc
-
14.12.1 Retrotope Inc Company Details
-
14.12.2 Retrotope Inc Friedreich Ataxia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Retrotope Inc Friedreich Ataxia Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Friedreich Ataxia Drug
-
Figure Friedreich Ataxia Drug Picture
-
Table Global Friedreich Ataxia Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Friedreich Ataxia Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Friedreich Ataxia Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Friedreich Ataxia Drug Consumption by Country (2017-2022)
-
Figure United States Friedreich Ataxia Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Friedreich Ataxia Drug Consumption and Growth Rate (2017-2022)
-
Figure China Friedreich Ataxia Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Friedreich Ataxia Drug Consumption and Growth Rate (2017-2022)
-
Figure India Friedreich Ataxia Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Friedreich Ataxia Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Friedreich Ataxia Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Friedreich Ataxia Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Friedreich Ataxia Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Friedreich Ataxia Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Friedreich Ataxia Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Friedreich Ataxia Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Friedreich Ataxia Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ADVM-063 Consumption and Growth Rate (2017-2022)
-
Figure Global AGIL-FA Consumption and Growth Rate (2017-2022)
-
Figure Global BHV-4157 Consumption and Growth Rate (2017-2022)
-
Figure Global BVA-202 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global ADVM-063 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AGIL-FA Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global BHV-4157 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global BVA-202 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Friedreich Ataxia Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Friedreich Ataxia Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Adverum Biotechnologies Inc (Foundation Year, Company Profile and etc.)
-
Table Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Adverum Biotechnologies Inc Friedreich Ataxia Drug Product and Service
-
Table RaNA Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table RaNA Therapeutics Inc Friedreich Ataxia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table RaNA Therapeutics Inc Friedreich Ataxia Drug Product and Service
-
Table ProQR Therapeutics NV (Foundation Year, Company Profile and etc.)
-
Table ProQR Therapeutics NV Friedreich Ataxia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table ProQR Therapeutics NV Friedreich Ataxia Drug Product and Service
-
Table Forward Pharma A/S (Foundation Year, Company Profile and etc.)
-
Table Forward Pharma A/S Friedreich Ataxia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Forward Pharma A/S Friedreich Ataxia Drug Product and Service
-
Table Shire Plc (Foundation Year, Company Profile and etc.)
-
Table Shire Plc Friedreich Ataxia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Plc Friedreich Ataxia Drug Product and Service
-
Table Reata Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Reata Pharmaceuticals Inc Friedreich Ataxia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Reata Pharmaceuticals Inc Friedreich Ataxia Drug Product and Service
-
Table Voyager Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Voyager Therapeutics Inc Friedreich Ataxia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Voyager Therapeutics Inc Friedreich Ataxia Drug Product and Service
-
Table Ixchel Pharma LLC (Foundation Year, Company Profile and etc.)
-
Table Ixchel Pharma LLC Friedreich Ataxia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ixchel Pharma LLC Friedreich Ataxia Drug Product and Service
-
Table STATegics Inc (Foundation Year, Company Profile and etc.)
-
Table STATegics Inc Friedreich Ataxia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table STATegics Inc Friedreich Ataxia Drug Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Friedreich Ataxia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Friedreich Ataxia Drug Product and Service
-
Table Cardero Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Cardero Therapeutics Inc Friedreich Ataxia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cardero Therapeutics Inc Friedreich Ataxia Drug Product and Service
-
Table Retrotope Inc (Foundation Year, Company Profile and etc.)
-
Table Retrotope Inc Friedreich Ataxia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Retrotope Inc Friedreich Ataxia Drug Product and Service
-
